<i>Escherichia coli</i> (Lilly) and <i>Saccharomyces cerevisiae</i> (Novo) rDNA Glucagon: An Assessment of Their Actions When Supplied Selectively to Periportal Cells in the Bivascularly Perfused Rat Liver

<i>Escherichia coli</i> (Lilly) and <i>Saccharomyces cerevisiae</i> (Novo) rDNA Glucagon: An Assessment of Their Actions When Supplied Selectively to Periportal Cells in the Bivascularly Perfused Rat Liver

The actions of Eli Lilly-rDNA glucagon and Novo Nordisk-rDNA glucagon on glycogen catabolism and related parameters were investigated using the bivascularly perfused rat liver. The technique allows glucagon to be supplied to a selective portion of the hepatic periportal region (≈39%) when the former...

Full description

Bibliographic Details
Main Authors: Lívia Bracht, Jorgete Constantin, Rosane Marina Peralta, Adelar Bracht
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Scientia Pharmaceutica
Subjects:
rDNA glucagon
liver
bivascular perfusion
signaling propagation
glycogenolysis
glycolysis
Online Access:https://www.mdpi.com/2218-0532/91/3/29

Internet

https://www.mdpi.com/2218-0532/91/3/29

Similar Items